Oh I agree, and TOB's post allows everyone to deal with the situation that is a win/win for the longs here that are in scope with the guidelines on the site. Those that can dish it out can, and those that can't can simply ignore it and post positive due diligence (Karin tends to do this). Sounds simple to me.

So, I'd like to know best sources for researching biotech stuff. There was a website that you could pay a subscription for and you could see timeframes for upcoming trials, reports etc. Wondering what the more articulate biotech investors have in their toolbox.